Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8453416 | Leukemia Research | 2017 | 6 Pages |
Abstract
Day 14 BM evaluations following 3Â +Â 7 induction are unable to accurately predict the ability to achieve a CR. Many patients will attain a CR despite no further chemotherapy. The decision to re-induce can be safely delayed in many patients, especially those with favorable risk cytogenetics.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Victoria R. Nachar, Anthony J. Perissinotti, Gianni B. Scappaticci, Dale L. Bixby, Bernard L. Marini,